- Home
- EPIX vs ONL Comparison
EPIX vs ONL Comparison
Compare EPIX & ONL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPIX
- ONL
- Stock Information
- Founded
- EPIX 2009
- ONL 2021
- Country
- EPIX Canada
- ONL United States
- Employees
- EPIX N/A
- ONL N/A
- Industry
- EPIX Biotechnology: Pharmaceutical Preparations
- ONL Real Estate Investment Trusts
- Sector
- EPIX Health Care
- ONL Real Estate
- Exchange
- EPIX Nasdaq
- ONL Nasdaq
- Market Cap
- EPIX 209.4M
- ONL 226.6M
- IPO Year
- EPIX N/A
- ONL N/A
- Fundamental
- Price
- EPIX $1.72
- ONL $3.84
- Analyst Decision
- EPIX Hold
- ONL Hold
- Analyst Count
- EPIX 4
- ONL 1
- Target Price
- EPIX $9.50
- ONL N/A
- AVG Volume (30 Days)
- EPIX 2.4M
- ONL 259.6K
- Earning Date
- EPIX 12-10-2024
- ONL 11-07-2024
- Dividend Yield
- EPIX N/A
- ONL 10.44%
- EPS Growth
- EPIX N/A
- ONL N/A
- EPS
- EPIX N/A
- ONL N/A
- Revenue
- EPIX N/A
- ONL $169,644,000.00
- Revenue This Year
- EPIX N/A
- ONL N/A
- Revenue Next Year
- EPIX N/A
- ONL N/A
- P/E Ratio
- EPIX N/A
- ONL N/A
- Revenue Growth
- EPIX N/A
- ONL N/A
- 52 Week Low
- EPIX $1.40
- ONL $3.01
- 52 Week High
- EPIX $11.67
- ONL $6.22
- Technical
- Relative Strength Index (RSI)
- EPIX 23.15
- ONL 45.60
- Support Level
- EPIX $1.75
- ONL $3.84
- Resistance Level
- EPIX $1.89
- ONL $4.01
- Average True Range (ATR)
- EPIX 0.19
- ONL 0.13
- MACD
- EPIX -0.10
- ONL -0.00
- Stochastic Oscillator
- EPIX 7.36
- ONL 36.26
About EPIX ESSA Pharma Inc.
ESSA Pharma Inc is a pharmaceutical company. The company is focused on the development of small molecule drugs for the treatment of castration-resistant prostate cancer. The company is developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival.
About ONL Orion Office REIT Inc.
Orion Office REIT Inc is a internally-managed REIT engaged in the ownership, acquisition, and management of a diversified portfolio of mission-critical and headquarters office buildings located in high quality suburban markets across the U.S. and leased on a single-tenant net lease basis to creditworthy clients. The portfolio of the company includes traditional office buildings, governmental offices, medical offices, laboratories, and others. The Company operates in one business segment: direct ownership and operation of commercial real estate.